IDENTIFYING THE MAJOR TISSUE RESERVOIRS IN SIV/SHIV INFECTED MACAQUES

识别 SIV/SHIV 感染猕猴的主要组织储存库

基本信息

  • 批准号:
    7716274
  • 负责人:
  • 金额:
    $ 6.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-21 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Eradication of HIV-1 from an infected individual cannot be achieved by current usage of antiretroviral therapy regimens. Viral reservoirs established early during the infection remain unaffected by anti-retroviral therapy for a long time and are able to replenish systemic infection upon interruption of the treatment. Simian immune deficiency virus-rhesus macaque models of AIDS are a useful model for studying HIV pathogenesis and vaccine efficacy. We have used this model to explore the possible role of viral reservoirs in macaques that control viral replication with those that have persistently high viremia in plasma. The existence of actively replicating viruses in tissues correlates with plasma viral load. Similarly more latently infected cells were detected in macaques with a high plasma viral load. Lymph nodes were found to be the major tissue reservoir of virus followed by spleen, and intestinal tissues. Persistently infected cells in brain and thymus were detected in macaques with SIV-encephalitis. Therefore, anti-retroviral therapy should be designed in such a way that it can target infected cells in secondary lymphoid organs and reduce the generation of latently and persistently infected cells. T helper cells and macrophages were found to be the major cells that harbor persistently and latently infected cells, thus a vaccine or antiretroviral therapy should be specifically designed to protect these cells.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bapi Pahar其他文献

Bapi Pahar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bapi Pahar', 18)}}的其他基金

Impact of HIV/SIV Infection on Paneth and Intestinal Stem Cell Interaction
HIV/SIV 感染对潘氏和肠道干细胞相互作用的影响
  • 批准号:
    9349058
  • 财政年份:
    2017
  • 资助金额:
    $ 6.46万
  • 项目类别:
IMPORTANCE OF ANTIGEN SPECIFIC IGA RESPONSES IN CONTROLLING SIV/SHIV INFECTION
抗原特异性 IGA 反应在控制 SIV/SHIV 感染中的重要性
  • 批准号:
    8359778
  • 财政年份:
    2011
  • 资助金额:
    $ 6.46万
  • 项目类别:
DOUBLE POSITIVE CD21+CD27+ B CELLS ARE IN MUCOSAL AND PERIPHERAL TISSUES
粘膜和外周组织中存在双阳性 CD21 CD27 B 细胞
  • 批准号:
    8358167
  • 财政年份:
    2011
  • 资助金额:
    $ 6.46万
  • 项目类别:
IMPORTANCE OF ANTIGEN SPECIFIC IGA RESPONSES IN CONTROLLING SIV/SHIV INFECTION
抗原特异性 IGA 反应在控制 SIV/SHIV 感染中的重要性
  • 批准号:
    8358094
  • 财政年份:
    2011
  • 资助金额:
    $ 6.46万
  • 项目类别:
IMPORTANCE OF ANTIGEN SPECIFIC IGA RESPONSES IN CONTROLLING SIV/SHIV INFECTION
抗原特异性 IGA 反应在控制 SIV/SHIV 感染中的重要性
  • 批准号:
    8172998
  • 财政年份:
    2010
  • 资助金额:
    $ 6.46万
  • 项目类别:
IMPORTANCE OF ANTIGEN SPECIFIC IGA RESPONSES IN CONTROLLING SIV/SHIV INFECTION
抗原特异性 IGA 反应在控制 SIV/SHIV 感染中的重要性
  • 批准号:
    8167887
  • 财政年份:
    2010
  • 资助金额:
    $ 6.46万
  • 项目类别:
Importance of antigen specific immunoglobulin responses in controlling SIV/SHIV i
抗原特异性免疫球蛋白反应在控制 SIV/SHIV 中的重要性 i
  • 批准号:
    7929535
  • 财政年份:
    2009
  • 资助金额:
    $ 6.46万
  • 项目类别:
IMPORTANCE OF ANTIGEN SPECIFIC IGA RESPONSES IN CONTROLLING SIV/SHIV INFECTION
抗原特异性 IGA 反应在控制 SIV/SHIV 感染中的重要性
  • 批准号:
    7960596
  • 财政年份:
    2009
  • 资助金额:
    $ 6.46万
  • 项目类别:
IMPORTANCE OF ANTIGEN SPECIFIC IGA RESPONSES IN CONTROLLING SIV/SHIV INFECTION
抗原特异性 IGA 反应在控制 SIV/SHIV 感染中的重要性
  • 批准号:
    7958680
  • 财政年份:
    2009
  • 资助金额:
    $ 6.46万
  • 项目类别:
Importance of antigen specific immunoglobulin responses in controlling SIV/SHIV i
抗原特异性免疫球蛋白反应在控制 SIV/SHIV 中的重要性 i
  • 批准号:
    7554947
  • 财政年份:
    2009
  • 资助金额:
    $ 6.46万
  • 项目类别:

相似海外基金

RESISTANCE OF HIV-1 TO ANTI-RETROVIRAL AGENTS
HIV-1 对抗逆转录病毒药物的耐药性
  • 批准号:
    3030975
  • 财政年份:
    1993
  • 资助金额:
    $ 6.46万
  • 项目类别:
POLYMERICS DELIVERY SYSTEMS FOR ANTI-RETROVIRAL AGENTS
抗逆转录病毒药物的聚合物递送系统
  • 批准号:
    3489187
  • 财政年份:
    1990
  • 资助金额:
    $ 6.46万
  • 项目类别:
DEVELOPMENTAL VIROLOGY RESEARCH--RESISTANCE TO ANTI-RETROVIRAL AGENTS
发育病毒学研究——抗逆转录病毒药物的耐药性
  • 批准号:
    2335293
  • 财政年份:
  • 资助金额:
    $ 6.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了